Podcast

Darryl Hudson is Developing Psilocybin-Based Therapeutics – Podcast Episode #38

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals. Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries. GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development…

Christi Myers Believes in the Power of Dissociative Therapy – Podcast Episode #37

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Christi Myers, the Founder and CEO of Flow Integrative. Christi is a passionate advocate for the human potential and the transformative benefits of psychedelic wellness. As the Founder and CEO of Flow Integrative, she has dedicated herself to creating a platform…

Jennifer Chesak Writes About Psilocybin and Women – Podcast Episode #36

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jennifer Chesak, the author of The Psilocybin Handbook for Women. Jennifer is the author of the forthcoming book “Psilocybin for Women,” to be published by Ulysses Press and distributed by Simon & Schuster in 2023. She is a Nashville-based freelance journalist,…

James Gilligan is Leading the Next Wave of Psilocybin – Podcast Episode #35

Welcome to the fourth season of the Psychedelic Invest Podcast! It’s great to be back! On the season premiere episode, host Bruce Eckfeldt is joined by James Gilligan, the CEO of Tryp Therapeutics. Jim received his Ph.D. in Pharmacology and Toxicology from the University of Connecticut; he continued his post graduate education at the Roche…